Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMJGTS7)

Drug Name

4-(piperazin-1-yl)thieno[3,2-c]pyridine Drug Info

Synonyms

106261-27-2; 4-(piperazin-1-yl)thieno[3,2-c]pyridine; 1-{THIENO[3,2-C]PYRIDIN-4-YL}PIPERAZINE; Thieno[3,2-c]pyridine,4-(1-piperazinyl)-; Thieno[3,2-c]pyridine, 4-(1-piperazinyl)-; 4-Piperazin-1-yl-thieno[3,2-c]pyridine; CHEMBL608135; 4-Piperazin-1-ylthieno[3,2-c]pyridine; CHEMBL552833; 4-(1-piperazinyl)thieno[3,2-c]pyridine; 4-piperazine-1-yl-thieno[3,2-c]pyridine; 4-Piperazine-1-yl-thieno[2,3-c]pyridine hydrochloride; ACMC-1BO03; SCHEMBL616087; CTK4A4454; DTXSID10450113; MolPort-002-500-678; RVGRTFBJOXMFAX-UHFFFAOYSA-N

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 10966027
CAS Number: CAS 106261-27-2
TTD Drug ID: DMJGTS7

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
5-HT 2C receptor (HTR2C)	TTWJBZ5	5HT2C_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
5-HT 2C receptor (HTR2C)	DTT	HTR2C	4.233	3.329	3.843	3.888

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
5-HT 2C receptor (HTR2C)	DTT	HTR2C	1.02E-02	-0.45	-0.37
5-HT 2C receptor (HTR2C)	DTT	HTR2C	2.27E-01	0.27	0.6

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity. Bioorg Med Chem Lett. 2010 Jan 1;20(1):266-71.